Radcliffe Capital Management’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-176,346
Closed -$1.73M 1107
2022
Q3
$1.73M Buy
176,346
+33,745
+24% +$331K 0.04% 717
2022
Q2
$1.4M Buy
142,601
+44,337
+45% +$434K 0.03% 837
2022
Q1
$962K Buy
+98,264
New +$957K 0.02% 998

Radcliffe Capital Management's RACB Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Research Alliance Corp. II Class A Common Stock (RACB) in Q4 2022, closing a stake of 176,346 shares — an estimated $1.73M sold.

Radcliffe Capital Management first reported a position in RACB in Q1 2022 and held it in 3 quarters. The position peaked at $1.73M in Q3 2022. 0 funds tracked by Wall St. Rank hold RACB as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Research Alliance Corp. II Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 176,346 Research Alliance Corp. II Class A Common Stock shares in Q4 2022, an estimated $1.73M.
  • Radcliffe Capital Management first reported a position in Research Alliance Corp. II Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Radcliffe Capital Management's Research Alliance Corp. II Class A Common Stock position peaked at $1.73M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Research Alliance Corp. II Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.